Esophageal Cancer. Malignant neoplasm of oesophagus
Conditions
Interventions
Intervention 1: Intervention group: Capsule sponge examination for collecting cytological sampling form the esophagus. Intervention 2: Control group: No intervention.
Early detection
Intervention group: Capsule sponge examination for collecting cytological sampling form the esophagus
Control group: No intervention
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: Major criteria for inclusion: Age higher than 50 years; Living in Eastern Golestan for at least 10 years Major criteria for exclusion: History of malignant disease; liver cirrhosis; chronic renal failure
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of esophageal squamous cell carcinoma. Timepoint: After finishing the study. Method of measurement: Personal interview and reviewing patients' medical files.;Death from esophageal squamous cell carcinoma. Timepoint: After finishing the study. Method of measurement: Personal interview and reviewing patients' medical files.;Death from all causes. Timepoint: After finishing the study. Method of measurement: Personal interview and reviewing patients' medical files. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of esophageal adenocarcinoma. Timepoint: After finishing the study. Method of measurement: Personal interview and reviewing patients' medical files.;Change in quality of life. Timepoint: Before starting and after finishing the study. Method of measurement: Using a standard quality of life questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Gholamreza Roshandel
Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences
Outcome results
None listed